Dare Bioscience (DARE) Profit After Tax (2013 - 2026)

Dare Bioscience (DARE) has 13 years of Profit After Tax data on file, last reported at -$1.5 million in Q4 2025.

• Quarterly Profit After Tax rose 73.34% year-over-year to -$1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$13.4 million (down 233.21% YoY) and the FY2025 annual result came in at -$13.4 million, down 230.38% from the prior year.
• Profit After Tax rose to -$1.5 million in Q4 2025, from -$3.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $12.9 million in Q2 2024 to a low of -$15.9 million in Q4 2022.
• A 5-year average of -$5.9 million and a median of -$6.9 million in 2022 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2023 — Profit After Tax sank 2216.49% — and 2024, when it surged 247.34%.
• Tracing DARE's Profit After Tax over 5 years: stood at -$9.6 million in 2021, then tumbled by 65.97% to -$15.9 million in 2022, then jumped by 68.71% to -$5.0 million in 2023, then slipped by 10.33% to -$5.5 million in 2024, then jumped by 73.34% to -$1.5 million in 2025.
• The last three Profit After Tax figures came in at -$1.5 million (Q4 2025), -$3.6 million (Q3 2025), and -$4.0 million (Q2 2025), per Business Quant data.